As an union of Belgian federations (UNESSA, Zorgnet-Icuro, GIBBIS and Santhea), we feel that a European approach to the supply of critical medicines is both relevant and necessary, and any regulation in this area must be grounded in a thorough impact assessment that considers the entire medicinal product chain, from production to consumption.
UNE
UNESSA
NGO · Belgium · EU Transparency Register 810206551176-16
2
positions filed
in the 673 files tracked
1
legislative file
of 673 tracked
2
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 673 consultation files tracked so far (58,314 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1109 non-governmental organisations on this site, they rank #748 by legislative files engaged, a count of participation, not a measure of influence.
1
declared lobbying FTE
self-declared
–
declared costs / yr (floor)
1
EP accreditations
as declared to the register
2023
in the register since
Declares membership of
- MHE - Mental Health Europe
- CEC- Comité Européen de Coordination
- UNIPSO
- BRUXEO
Self-declared to the EU Transparency Register (snapshot 20 Oct 2026).
- Register category
- Non-governmental organisations
- Head office
- Namur, Belgium
- EU office
- Bruxelles
Self-declared to the EU Transparency Register (snapshot 20 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track UNESSA in PolicySpeak: request access →
Work at UNESSA? so we know who speaks for it.
Their record over time
UNESSA filed 2 positions between 27 Feb 2025 and 4 Jul 2025, across 1 of the 673 legislative files tracked here, attaching a full position paper 2 times.
What they argued
UNESSA (Belgium), the Federation of Care, Support, Assistance, and Personal Care, wishes to highlight several key elements regarding the future Critical Medicines Act. It emphasizes the relevance and necessity of a European approach to ensuring the supply of critical medicines. A coordinated strategy at the European level is essential to guarantee the availability of these medicines and prevent shortages.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put UNESSA next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from UNESSA’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.